Mark Budd

Commercialisation

Delivering ground breaking medical innovation to a patient’s bedside relies on the expertise of professionals in Leadership, Product Launch, Market Access, Marketing and Sales, and these are core to our heritage. Led by our client Partner, Mark Budd, and supported closely by CEO, Greg Bell, our commercialisation practice has extensive global networks which deliver an A Class team alongside your A Class medicine.

Board, C-suite, Leadership

Great science deserves great teams and great teams need exceptional leadership. This applies right across the whole value chain from Drug Development through to Commercialisation, and getting the right leadership team in place early is a critical success factor. We have an enviable track record of advising and building top Boards and Leadership teams globally, spearheaded by CEO and Founder, Greg Bell, ably supported Sean Morgan-Jones (CCO) and Client Partners, Georgia Attwood and Mark Budd.

Clinical Development

Led by our Client Partner, Georgia Attwood, the clinical development team support clients from Pre-Clinical through clinical phases I to III. We strengthen Boards and Leadership teams to develop their science in preparation for commercialisation or acquisition. We work with true start-up Biotech companies in rare, orphan, and speciality diseases, where science can have a real impact on patient lives.

Medical Affairs

Our clients are focused on leading edge scientific innovation, making Medical and Medical Affairs a pivotal function. Simon Felton, one of the sector’s most knowledgeable and experienced consultants, leads this practice. Simon, together with his team, can build a client’s entire medical function across Europe and North America, from global and above-country senior leadership through to in-country affiliate build out. Our multilingual team of experts work on business-critical projects from Chief Medical Officer recruitment through to building entire teams of MSLs.

Digital Health, Artificial Intelligence & Machine Learning

Our Digital Health (DH), Artificial Intelligence (AI) and Machine Learning (ML) division is led by Nic Jen (BEng), supported by a dedicated team of Resourcers and Researchers.

Advancing technologies such as AI and ML have strengthened data generation and therefore collection. This drives better insights which leads to a faster decision-making process for medicines and Medical Technology. Our team work globally and are experts in supporting start-ups and established companies build or add to their Executive and Leadership teams.

Medical Technology

Our Medical Technology (Devices) team is led Peter Reynolds, supported by a dedicated team of Resourcers and Researchers spanning Europe and the US. With more than 500,000 medical technologies available today, and new innovations expanding those numbers exponentially, our MedTech team work tirelessly with clients around the world to bring leading edge talent to leading edge technologies. They share a common purpose of improving, extending, and transforming people’s lives.